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Abstract 1 
 2 
Stair negotiation poses a substantial physical demand on the musculoskeletal system and this 3 
challenging task can place individuals at risk of falls. Peripheral arterial disease (PAD) can 4 
cause intermittent claudication (IC) pain in the calf and results in altered gait mechanics during 5 
level walking. However, whether those with PAD-IC adopt alternate strategies to climb stairs 6 
is unknown. Twelve participants with PAD-IC (six bilateral and six unilateral) and 10 healthy 7 
controls were recruited and instructed to ascend a five-step staircase whilst 3D kinematic data 8 
of the lower-limbs were recorded synchronously with kinetic data from force plates embedded 9 
into the staircase on steps two and three. Limbs from the unilateral group and both limbs from 10 
the bilateral claudicants were categorised as claudicating (N=18), asymptomatic (N=6) and 11 
control (N=10). Claudicants walked more slowly than healthy controls (trend; P=<.066). Both 12 
claudicating- and asymptomatic-limb groups had reduced propulsive GRF (P=.025 and P=.002, 13 
respectively) and vertical GRF (P=.005 and P=.001, respectively) compared to controls. The 14 
claudicating-limb group had a reduced knee extensor moment during forward continuance 15 
(P=.060), ankle angular velocity at peak moment (P=.039) and ankle power generation 16 
(P=.055) compared to the controls. The slower gait speed, irrespective of laterality of 17 
symptoms, indicates functional capacity was determined by the limitations of the claudicating 18 
limb. Reduced ankle power generation and angular velocity (despite adequate plantarflexor 19 
moment) implies velocity-dependent limitations existed in the calf. The lack of notable 20 
compensatory strategies indicates reliance on an impaired muscle group to accomplish this 21 
potentially hazardous task, highlighting the importance of maintaining plantarflexor strength 22 
and power in those with PAD-IC.  23 
2 
 
 
Introduction 1 
Peripheral arterial disease (PAD) is a chronic atherosclerotic disease of the peripheral arteries, 2 
primarily affecting the legs in older adults, with prevalence increasing with advancing age1. 3 
The disease negatively impacts on quality of life2 and functional ability3, with walking 4 
endurance declining with disease progression4. Alterations in gait biomechanics have been 5 
reported in proximal muscle groups (i.e. knee and hip extensors) as well as the plantarflexors5,6, 6 
which are also a frequently reported site of intermittent claudication pain7. Ambulation over 7 
level ground is functionally important, however, the ability to negotiate stairs is also vital to 8 
maintaining functional independence8. There is a high incidence of falls among the elderly 9 
during stair walking9,10, and balance, alongside lower limb strength, are vital pre-requisites to 10 
perform this task11,12. Given the previously reported impairments in balance13,14, and reduced 11 
lower limb strength15-17 of claudicants, stair negotiation likely poses a highly physically 12 
challenging and potentially hazardous task for this group of older adults.  13 
 14 
Not only does stair negotiation place more demands on the lower limbs compared to level 15 
gait12,18, but specific age-related adaptations also occur. The requirement to develop muscular 16 
force during stair ascent compared to the muscular capabilities is much greater for the healthy 17 
elderly than the young. The knee extensors in older adults work at 75% of their maximum 18 
capacity (quantified through isokinetic dynamometry) compared to 53% in younger adults19 19 
and, in some cases, operate in excess of their maximum measured strength at the knee20. A 20 
similar effect is evident at the ankle (elderly 93% vs young 85%)19 with both the soleus 21 
muscle21 and the gastrocnemii22 playing important roles in raising the body to the next step in 22 
forward continuance.  23 
 24 
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It is evident that the gastrocnemii, in particular, are impaired in claudicants as there are signs 1 
of fibre type adaptations23,24, infiltration of intra-muscular fat25, neuromuscular impairments26 2 
and, more recently, adaptations in the structure of the gastrocnemii muscle and Achilles 3 
tendon17,27. Moreover, there is clear dysfunction in level gait with reduced plantarflexor 4 
moments and subsequently smaller power generation at push-off, which worsens in the 5 
presence of claudication pain5,6,28. However, it remains unknown how those with PAD-IC 6 
actually cope with the increased demands of stair ascent. 7 
 8 
The purpose of the study was to determine whether individuals with PAD-IC adopt altered 9 
biomechanical profiles during stair ascent. This was achieved by comparing discrete 10 
parameters within the gait cycle to a control group consisting of healthy older adults, and 11 
exploring relationships between gait parameters and disease severity. It was hypothesised that 12 
claudicants would have reduced peak plantarflexor moment and ankle power generation 13 
compared to controls and adopt compensatory strategies at the knee and/or hip. Our second 14 
hypothesis was that reduced plantarflexor function would be associated with a reduced ankle 15 
brachial pressure index (ABPI), an indicator of disease severity in patients with PAD-IC. 16 
 17 
Methods 18 
Participants 19 
Ethical approval was granted by the National Health Service Research Ethics Committee (REC 20 
reference: 11/YH/0335). Twenty-two participants were recruited, consisting of 12 individuals 21 
with PAD-IC (six unilateral, six bilateral) and 10 healthy controls (Table 1). PAD-IC patients 22 
were recruited from a local outpatient vascular clinic. Male and female participants aged 23 
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between 55-80 years diagnosed with Grade 1 Chronic Limb Ischemia29 with an arterial 1 
narrowing of the superficial femoral artery were considered for inclusion. Healthy aged-2 
matched controls were recruited from the local community. Individuals deemed to have severe 3 
or acute cardiovascular, musculoskeletal or pulmonary illness, history of neurological 4 
disorders, stroke, myocardial infarction or life-limiting diseases were excluded along with 5 
those with a previous lower-limb joint replacement and observable gait abnormalities or who 6 
required a walking aid. 7 
 8 
Disease severity 9 
Disease severity was determined using the ankle brachial pressure index (ABPI). ABPI 10 
measures for both lower limbs were taken pre- and post- a standardised exercise protocol 11 
performed on a motorised treadmill (5 minutes at 2.5km/h at 10% incline). Systolic blood 12 
pressure was measured in the posterior tibial and dorsalis pedis arteries of each leg and the 13 
brachial pressure of both arms, separately, using a sphygmomanometer cuff and a handheld 14 
Doppler instrument (Parks Medical Electronics Inc, Oregon, USA). In accordance with 15 
standard protocol, the ABPI for both legs was then calculated as the higher of the two leg artery 16 
pressures normalised to the higher brachial pressure of the two arms7. The post-exercise ABPI 17 
was used to identify the ‘claudicating-limb’ group (N=12 providing a total of 18 limbs; 12 from 18 
bilateral claudicants and 6 from unilateral claudicants) and the ‘asymptomatic-limb’ group 19 
(N=6 providing a total of 6 limbs from the unilateral claudicants). Whilst this creates a 20 
statistical imbalance between groups, to truly understand movement patterns within this cohort, 21 
potential adaptations in the asymptomatic limb as a compensatory mechanism for the more 22 
painful symptomatic limb must be explored. This method also assumes the asymptomatic limb 23 
is independent of the claudicating limb and although this contradicts the statistical rule of 24 
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independent samples, as the disease is unilateral in nature, the clinical presentations are 1 
different. The functional consequences may also differ therefore we believe this method of 2 
investigation is justified. Control participants also undertook the exercise protocol to determine 3 
ABPI values, to confirm the absence of PAD-IC. For brevity, only the dominant limb of the 4 
control participants, determined through a ball-kicking task, is presented. 5 
 6 
Experimental protocol 7 
Ten Qualisys Oqus 400 cameras (Qualisys, Gothenburg, Sweden) and 2 Kistler force plates 8 
(model 9286AA, Kistler, Winterthur, Switzerland), sampling at 100Hz and 1000Hz, 9 
respectively, were synchronised and collected kinematic and kinetic data. A total of 47 retro-10 
reflective passive markers (14mm diameter) were positioned according to the six Degrees-of-11 
Freedom marker set30. Functional movements were used to define the hip joint centre31. 12 
Participants were asked to ascend a custom-made five-step wooden staircase (step height; 13 
20cm, step tread; 25cm, step width; 80cm) in a step-over-step manner. The staircase was 14 
instrumented with force plates embedded into steps two and three (step 5 being the top landing), 15 
and the top landing of the staircase was 1 metre in length. A 3m walkway in-front of the 16 
staircase allowed for steady-state level gait speed to be reached prior to stair ascent. The 1m 17 
top landing also allowed approximately two steps to be taken after participants ascended the 18 
staircase to avoid participants stopping on the last step. The staircase was equipped with a 19 
safety handrail and participants were instructed to use it only when necessary. Even light 20 
handrail influences lower limb kinetics during stair ascent32 therefore, trials in which the 21 
participant used the handrail were excluded from further analysis. Our staircase has previously 22 
been shown to be rigid with negligible artefact or power lost from the force plate signals at 23 
physiologically relevant frequencies33. 24 
6 
 
 
 1 
Data analysis 2 
3D coordinate data were tracked using Qualysis Track Manager (V2.8, Qualysis, Gothenburg, 3 
Sweden) then exported for further processing in Visual 3D (V4, C-motion, Rockville, MD, 4 
USA). Coordinate data were interpolated using a cubic spline algorithm and both marker and 5 
kinetic data were filtered using a 2nd order low-pass Butterworth filter with a cut-off frequency 6 
of 6Hz for kinematic data and 15Hz for kinetic data. The focus of the present study was 7 
continuous, steady state stair ascent therefore one gait cycle was defined from foot contact on 8 
step 2 to the subsequent foot contact of the ipsilateral limb on step 4; and from foot contact on 9 
step 3 to the subsequent foot contact of the ipsilateral limb on step 5 for the contralateral limb. 10 
Lead limb preference for ascending the stairs was explored; no preferential strategy was evident 11 
for all participants and therefore not assessed further. Relevant gait events were identified (foot 12 
strike and foot off) using vertical ground reaction force (≥20 N and ≤20 N threshold for foot 13 
strike and foot off, respectively), and were normalised to 100% gait cycle for kinetic parameters 14 
and 100% stance phase for ground reaction forces. Sub-phases of gait were defined according 15 
to McFaydon & Winter (1998)21: weight acceptance, pull-up, forward continuance, foot 16 
clearance and foot placement. Variables of interest included temporal-spatial parameters, 17 
sagittal plane angular velocities, 3-dimensional ground reaction forces (GRF), sagittal plane 18 
kinetics (peak joint moments and powers), and angular velocities at the instant of peak moment 19 
for the hip, knee and ankle joints. Walking speed was determined over one gait cycle using gait 20 
events previously determined within Visual 3D. Angular velocities at the instant of peak 21 
moment occurred during weight acceptance for the hip and knee, and during forward 22 
continuance for the ankle. Positive angular velocities indicate changes in joint angle towards 23 
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ankle dorsiflexion, knee flexion and hip flexion. Data are expressed as mean and standard 1 
deviation. 2 
 3 
Statistical analysis 4 
Data were exported into SPSS v21.1 (SPSS Inc., Chicago, IL, USA), assessed for normality 5 
violations using Shapiro-Wilk’s test for normality and assessed for outliers through box plot 6 
analysis. Demographic data were non-parametric so an independent samples Kruskal-Wallis 7 
test was performed with subsequent pairwise comparisons where appropriate. To avoid 8 
violating the assumption of independent samples, only the bilateral claudicants were included 9 
in the claudicating-limb group and unilateral claudicants in the asymptomatic-limb group for 10 
between-group analysis of walking speed and time spent in double support. As groups differed 11 
in walking speed between the bilateral and unilateral claudicants compared to healthy controls, 12 
a univariate analysis of variance was performed between control, claudicating limb and 13 
asymptomatic limb groups for joint kinetics and GRF with walking speed as a covariate. Where 14 
a significant interaction effect was observed, a Sidak post-hoc comparison was performed. A 15 
Pearson’s partial product-moment correlation was performed to assess relationships between 16 
disease severity (as assessed by ABPI and controlled for the influence of age) and gait 17 
parameters for the claudicant group only. For all statistical tests, significance was accepted at 18 
P≤.05 and trends were accepted at P<.10. For correlation analyses, a moderate relationship was 19 
accepted as R=.40–.59, a strong relationship was accepted as R=.60–.79 and a very strong 20 
relationship was accepted as R=.80–134.  21 
 22 
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Results 1 
No significant differences were found between groups in age (P=.148), height (P=.230), or 2 
mass (P=.167) (Table I).  Due to the bilateral nature of determining walking speed and to avoid 3 
violating the assumption of independent samples, walking speed and double support time were 4 
compared between bilateral and unilateral claudicants and healthy controls. Compared to the 5 
control group, trends towards slower walking speed than controls were evident in both the 6 
bilateral claudicant (0.71±0.09m/s vs 0.60±0.10m/s, P=.051) and the unilateral claudicant 7 
(0.71±0.09m/s vs 0.60±0.12m/s, P=.066) groups. Furthermore, unilateral claudicants spent 8 
significantly longer in double support compared to healthy controls (28.7±4.7% vs 20.2±6.2%, 9 
P=.018) with bilateral claudicants demonstrating similar trends (27.4±4.1 vs 20.2±6.2%, 10 
P=.088).  11 
 12 
Table I. Participant characteristics. Data are presented as group mean (SD) unless otherwise 13 
stated 14 
BMI – Body mass index, ABPI – Ankle brachial pressure index.  15 
 
Claudicating-
limb 
Asymptomatic-
limb Control 
# 12 6 10 
Limbs for analysis 18 6 10 
% Males 83 67 40 
Age (years) 64.7 (7.1) 67.3 (7.5) 61.6 (3.6) 
Height (m) 1.72 (0.08) 1.70 (0.11) 1.66 (0.09) 
Mass (Kg) 83.3 (18.8) 83.9 (22.6) 72.3 (10.9) 
BMI (Kg/m2) 28.0 (5.2) 28.8 (5.2) 26.1 (3.7) 
ABPI pre-exercise 
ABPI post-exercise 
0.80 (0.21) 1.00 (0.12) 1.01 (0.09) 
0.56 (0.20) 0.91 (0.08) 1.00 (0.16) 
% Hypertension 50 50 10 
% Hypercholesterolemia 58 67 20 
% past smokers 50 50 30 
% present smokers 50 50 0 
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Ground reaction forces and joint kinetics 1 
Both the claudicating-limb and asymptomatic-limb groups had significantly reduced 2 
propulsive GRF (P=.025 and P=.002, respectively) and vertical GRF (P=.005 and P=.001, 3 
respectively) in forward continuance compared to healthy controls (Table II and Figure 1). 4 
Furthermore, the claudicating-limb group demonstrated trends towards increased braking force 5 
in early stance (P=.087), reduced knee extensor moment in forward continuance (P=.060) and 6 
ankle power generation (P=.055) compared to healthy controls. The claudicating-limb group 7 
had significantly reduced ankle angular velocity at the instant of peak plantarflexor moment 8 
(P=.039) compared to healthy controls (Table III). 9 
 10 
Table II. Peak group mean (SD) ground reaction forces. * represent between-group differences 11 
reaching significance (P≤.05) and ^ represent those demonstrating trends towards significance 12 
(P<.10). Con = vs healthy control group. Positive values indicate medial, anterior and vertical 13 
force 14 
 15 
GRF (N/BW) Claudicating-limb 
Asymptomatic-
limb Control 
Medial during weight acceptance 0.60 (0.14) 0.49 (0.14) 0.54 (0.03) 
Medial during forward continuance 0.55 (0.15) 0.47 (0.12) 0.60 (0.23) 
Posterior during weight acceptance -0.97 (0.33)^Con -0.76 (0.26) -0.71 (0.18) 
Anterior during forward continuance 0.57 (0.14)*Con 0.44 (0.12)*Con 0.76 (0.10) 
Vertical during weight acceptance 1.06 (0.13) 1.05 (0.11) 1.11 (0.13) 
Vertical during forward continuance 1.15 (0.10)*Con 1.14 (0.22)*Con 1.53 (0.28) 
 16 
  17 
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Table III. Peak group mean (SD) sagittal plane joint kinetics and angular velocities. Peak 1 
moments occurred during weight acceptance for the hip and knee, and during forward 2 
acceptance for the ankle. * represent between-group differences reaching significance (P≤.05) 3 
and ^ represent those demonstrating trends towards significance (P<.10). Con = vs healthy 4 
control group. Positive values indicate hip extensor, knee extensor, ankle plantarflexor and 5 
power generation. 6 
 7 
 8 
  9 
Sagittal plane joint moments (Nm/kg) 
and angular velocities (°/s) 
Claudicating-
limb 
Asymptomatic-
limb Control 
Hip moment weight acceptance  0.91 (0.53) 0.84 (0.44) 1.16 (0.43) 
Peak angular velocity  245.1 (57.8) 237.8 (51.1) 257.2 (23.7) 
Angular velocity at peak moment  -103.5 (25.0) -101.8 (19.2) -137.2 (61.4) 
Knee moment weight acceptance  1.05 (0.28) 1.07 (0.32) 1.03 (0.23) 
Knee moment forward continuance -0.14 (0.15)*Con -0.07 (0.20) 0.51 (0.20) 
Peak angular velocity 213.0 (41.4)^Con 199.5 (32.3)^Con 281.2 (68.1) 
Angular velocity at peak moment 122.7 (34.0) 127.6 (14.0) 139.6 (33.9) 
Ankle moment weight acceptance 0.93 (0.48) 0.88 (0.23) 0.96 (0.40) 
Ankle moment forward continuance 1.44 (0.31) 1.69 (0.39) 1.66 (0.43) 
Peak angular velocity 198.4 (35.5) 231.1 (60.2) 229.5 (54.9) 
Angular velocity at peak moment -61.0 (22.4)*Con -82.4 (25.2) -93.3 (28.1) 
Joint powers (W/kg) Claudicating-limb 
Asymptomatic-
limb Control 
Hip power weight acceptance 2.11 (1.36) 1.97 (1.45) 2.90 (1.03) 
Knee power weight acceptance 2.48 (1.05) 2.50 (0.69) 2.55 (0.40) 
Ankle power forward continuance 3.36 (1.19)^Con 4.43 (1.13) 5.28 (1.93) 
13 
 
 
Disease severity correlations 1 
Increased disease severity was associated with increased peak medial GRF (R=-.630, P=.038) 2 
and trends towards reduced peak propulsive GRF during forward continuance (R=.601, 3 
P=.051), reduced knee extension moment during weight acceptance (R=.540, P=.086), and 4 
reduced peak knee angular velocity (R=-.554, P=.077). No association existed between overall 5 
walking speed of unilateral and bilateral claudicants, and disease severity (R=-.236, P.511). 6 
 7 
Discussion 8 
This study has, to the best of the authors’ knowledge, investigated stair ascent biomechanics in 9 
PAD-IC for the first time. The findings suggest that claudicants walk more slowly than healthy 10 
controls, irrespective of whether the arterial stenosis and claudication symptoms are present in 11 
a single limb or bilaterally. In partial support of our first hypothesis, plantarflexor power 12 
generation in late stance (forward continuance), alongside propulsive and vertical GRF, were 13 
smaller in the claudicating-limb group compared to healthy controls. The reduced power 14 
generation in the claudicating-limb group appears to result from a slower ankle joint velocity 15 
necessary to achieve adequate peak plantarflexor moment in late stance.  16 
 17 
The observed trends towards reduced ankle power generation in the forward continuance phase 18 
in the claudicating-limb group coincides with reduced angular velocity at peak moment, and 19 
reduced propulsive and vertical forces. This could be explained by the previous observation of 20 
reduced plantarflexor strength at high velocities17. Previous investigations into level gait 21 
mechanics have reported reduced plantarflexor moments in claudicants compared to healthy 22 
controls5,28,35. However, those studies also observed slower walking speeds in those with PAD-23 
14 
 
 
IC compared to healthy controls, therefore those previous findings may also reflect walking-1 
speed related gait differences and not solely reduced plantarflexor strength. A previous study 2 
on level gait mechanics compared claudicants to speed-matched controls6 and the present study 3 
statistically controlled for variance in walking speed, both of which observed reduced joint 4 
powers in claudicants, not reduced moments. Therefore, velocity-dependent limitations in 5 
claudicant plantarflexors appear a genuine adaptation. It seems that claudicants possess 6 
adequate levels of strength when moving more slowly but are unable to exert that strength 7 
when moving more quickly. Therefore, it could be suggested that the slower walking speed is 8 
a strategy to allow claudicants to operate within safer limits relative to their maximal strength 9 
capacity. Further investigation following a similar experimental protocol to Reeves et al. 10 
(2009)19 would be required to confirm these inferences. Nonetheless, these findings highlight 11 
the importance of maintaining plantarflexor strength, specifically plantarflexor power, in those 12 
with PAD-IC. Reductions in maximum strength capacity, without the adoption of adequate 13 
compensatory strategies, such as walking more slowly, would place excessive demands on the 14 
functionally-limited plantarflexors, thus jeopardising the ability to accomplish this task safely. 15 
 16 
It has previously been documented that healthy elderly adopt strategies to increase knee 17 
extensor moment in late stance (forward continuance) just prior to peak ankle moment19. Those 18 
authors suggested that was a mechanism to transfer energy from the proximal knee joint to the 19 
distal ankle joint via the bi-articular gastrocnemii muscles, enabling a greater peak ankle 20 
moment to be generated. A similar profile was exhibited in the present study by the healthy 21 
elderly group (Figure 2) but not by the claudicants (either claudicating-limb group or 22 
asymptomatic-limb group), indicating a functionally useful mechanism was not being utilised 23 
by the PAD-IC patients. An alternative compensation could be an increase in contralateral hip 24 
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extensor activity during the mid-stance pull-up phase. However, no such increase in hip 1 
moments or powers were observed for either the claudicating-limb or asymptomatic-limb 2 
groups (Figure 2). The reasons for this are unclear, however reduced hip extensor strength has 3 
previously been associated with increased disease severity and reduced functional mobility in 4 
claudicants36 and it may be that they lack adequate capacity to utilise such a compensation 5 
irrespective of the disease presence uni- or bi-laterally. Alternatively, it may simply be that the 6 
claudicants evade increased muscular effort in any lower limb muscle group as an attempt to 7 
avoid earlier onset of claudication pain and increased metabolic cost37. The lack of any 8 
observable compensatory strategy may also contribute to the aforementioned slower walking 9 
speed in claudicants as they are relying on the smaller, weaker and frequently symptomatic 10 
plantarflexor group to perform this task. 11 
 12 
Given the identified functional decline of the ankle musculature in the claudicating limbs, it 13 
may have been expected that, in unilateral claudicants, the asymptomatic limb would 14 
demonstrate compensatory hip and/or knee strategies. Interestingly however, the asymptomatic 15 
limb demonstrated similar adaptations to the claudicating limb with reduced propulsive and 16 
vertical forces, reduced peak knee angular velocity and a (non-significant) 16% reduction in 17 
ankle power generation compared to healthy controls. These findings are analogous to those 18 
investigations of unilateral claudicants during level gait5,6 and suggest that unilateral 19 
claudicants are functionally limited by the claudicating limb. This further highlights the 20 
importance of improving the strength and function of the claudicating limb, regardless of 21 
whether the disease is present in a single limb or both. 22 
 23 
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The present study investigated pain-free stair ascent only. Plantarflexor function during level 1 
gait deteriorates further in the presence of claudication pain5,38. It would be reasonable to 2 
assume that adaptations highlighted in the present study may be exacerbated detrimentally and 3 
extrapolated further during painful locomotion, however future investigation is needed to 4 
confirm this speculation. Whilst we statistically controlled for the influence of walking speed 5 
in between-group analyses, a more vigorous investigation comparing claudicants to speed-6 
matched controls is required to fully explore the velocity-dependent limitations in the 7 
gastrocnemii. Previous research has also demonstrated light handrail use influences gait 8 
biomechanics32 and the present study excluded trials in which participants used the handrail as 9 
the extent of handrail use and upper limb kinetics/force could not be quantified with our 10 
staircase design. However, given the reported balance deficits in the population13,14, handrail 11 
use, particularly in the presence of claudication pain for example, may play a larger 12 
compensatory role and requires further investigation.  13 
 14 
Conclusions 15 
This study provides evidence for specific limitations of the plantarflexor muscles during stair 16 
ascent in claudicants with peripheral arterial disease. There was a lack of notable hip or knee 17 
strategies in the claudicating limb as a compensatory mechanism for the clear, velocity-18 
dependent limitations of the plantarflexors. Similarly, in unilateral claudicants, there were no 19 
observable compensations from the asymptomatic limb. Thus, the stair climbing function of 20 
those with PAD-IC seems to be determined by the limitations of the claudicating limb, 21 
highlighting the importance of maintaining or improving strength and power in the 22 
plantarflexor muscle group. 23 
  24 
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